Please assess the completion status of the following clinical trial:

Trial Title: The Effect of Device Closure of Patent Foramen Ovale in Elderly Patients With Crytogenic Stoke/TCI

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Stroke or TIA within 30 days~* Above 50 years of age~Exclusion Criteria:~* Deceases og the esophagus~* Dementia~* Allergy to aspirin~* Risk of non-compliance~* Lacking ability to give written or oral consent~* Atrial Fibrillation~* Neurological deficit lasting less than 6 hours

- Gender: ALL
- Minimum Age: 51 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Device closure of PFO (Type: EXPERIMENTAL): Device closure of PFO followed by 6 month treatment with clopidogrel 75 mg and 75 - 150 mg of aspirin daily followed by a life long treatment with dipyridamol 200 mg twice daily plus 75-150 mg aspirin daily
- Medical anticoagulative treatment (Type: ACTIVE_COMPARATOR): Life long treatment with dipyridamol 200 mg twice daily plus 75-150 mg aspirin daily

Based on this trial design, predict the completion outcome and termination type (if applicable).